SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Fannie Lou Hamer Synthetic CCD — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientFannie Lou Hamer
Date of birth1917-10-06
IdentifiersMRN HR-ML031-SYN-TD; SSN (made up) 000-31-2479
Document date2026-11-01
AuthorLorraine Batiste-Hill, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Reason for Visit

Establishing care at the rural community health center for high blood pressure readings, thirst and frequent urination, leg and back aching, and reduced vision in the left eye since an old injury, with consent-based, trauma-informed care and a social needs screen. Concerns: She wants nothing done to her body without being told first what it is and why, and wants the right to say no; She wants to stay well enough to keep working for her community; She worries about the cost of medicines and getting to appointments. [S]

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Medications

MedicationFrequencyRouteDatesStatusEvidence
Metformin extended-release 500 mg oral tablet, one tablet with the evening meal for one week, then two tablets with the evening mealTwo tablets with the evening meal (after one week of one tablet)Oral route1967-03-09 to 1967-07-13completedS
Metformin extended-release 500 mg oral tablet, three tablets with the evening mealThree tablets with the evening mealOral route1967-07-13activeS
Atorvastatin 40 mg oral tablet, one tablet dailyOne tablet dailyOral route1967-03-09activeS
Amlodipine 5 mg and benazepril 20 mg combined oral capsule, one capsule dailyOne capsule dailyOral route1967-03-23activeS
Dapagliflozin 10 mg oral tablet, one tablet daily; stop on days of vomiting, diarrhea or not eating, and before surgeryOne tablet daily, with sick-day rulesOral route1967-03-23activeS

Procedures

ProcedureDatesStatusEvidence
Twelve-lead electrocardiogram, after the purpose was explained and she agreed, with a female assistant1967-03-09 to 1967-03-09completedS
Comprehensive diabetic foot examination with a 10-g monofilament, vibration and pulses, with her consent1967-03-09 to 1967-03-09completedS
Ultrasound of both kidneys and the bladder at the health center, after the purpose and steps were explained and she agreed, with a female sonographer and her chosen companion present1967-03-23 to 1967-03-23completedS
Retinal photographs of both eyes in the clinic without dilating drops, with her consent1967-05-04 to 1967-05-04completedS
Advance care planning conversation, about 25 minutes1967-09-14 to 1967-09-14completedS
Screening mammogram, both breasts, after the steps were explained and she agreed, with a female technologist and the community health worker accompanying her1967-10-05 to 1967-10-05completedS

Immunizations

DateVaccineStatusEvidence
1967-03-23Pneumococcal conjugate vaccine PCV20completedS
1967-03-23Hepatitis B vaccine (HepB-CpG), dose 1 of 2completedS
1967-03-23Tetanus, diphtheria, and acellular pertussis vaccine (Tdap)completedS
1967-05-04Hepatitis B vaccine (HepB-CpG), dose 2 of 2completedS
1967-10-19Influenza vaccine, inactivated, this seasoncompletedS
1967-10-19COVID-19 vaccine, mRNA, this seasoncompletedS
1967-10-19Recombinant zoster vaccine, dose 1 of 2completedS

Past Medical History

Historical biography with true dates. These events are not part of the synthetic care timeline.

Historical dateHistoryEvidence
1961Operation to remove a uterine tumor, during which a hysterectomy was performed without her knowledge or informed consent; she calls it a "Mississippi appendectomy". Whether the cervix was removed is not known; no operative record is availableD (CLM-0003)
June 9, 1963Beaten in the Winona jail, with lasting injuries: permanent kidney damage, a blood clot in the left eye with reduced vision in that eye, and injuries to her legsD (CLM-0005, CLM-0006)

Family History

No family medical history is documented in the logged sources. Family history of real relatives is recorded only from documented or retrospective sources and is never synthesized.

Health Concerns

ConcernStatusEvidence
She wants nothing done to her body without being told first what it is and why, and wants the right to say noactiveS
She wants to stay well enough to keep working for her communityactiveS
She worries about the cost of medicines and getting to appointmentsactiveS

Assessment

Most recent measures: Hemoglobin A1c/Hemoglobin.total in Blood 6.9 on 1967-10-19; Glucose [Mass/volume] in Serum or Plasma 238 on 1967-03-09; Sodium [Moles/volume] in Serum or Plasma 140 on 1967-05-04; Potassium [Moles/volume] in Serum or Plasma 4.5 on 1967-10-19; Creatinine [Mass/volume] in Serum or Plasma 1 on 1967-10-19; Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1962)/1.73 sq M 69 on 1967-10-19; Albumin/Creatinine [Mass Ratio] in Urine 41 on 1967-10-19; Cholesterol [Mass/volume] in Serum or Plasma 154 on 1967-05-04; Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 80 on 1967-05-04; Cholesterol in HDL [Mass/volume] in Serum or Plasma 46 on 1967-05-04; Triglyceride [Mass/volume] in Serum or Plasma 142 on 1967-05-04; Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 26 on 1967-05-04; Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 22 on 1967-03-09; Hemoglobin [Mass/volume] in Blood 12.6 on 1967-03-09; Platelets [#/volume] in Blood by Automated count 268 on 1967-03-09; Thyrotropin [Units/volume] in Serum or Plasma 2.1 on 1967-03-09; Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 3 on 1967-07-13; Accountable health communities (AHC) health-related social needs screening (HRSN) tool 1 on 1967-10-19; Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 0 on 1967-09-14 [S]

Strengths and supports: engagement in care [S]

Problems

ProblemClinical statusVerificationCodeProvenance
Type 2 diabetes with hyperglycemia, newly diagnosed: A1c 8.6% and random glucose 238 mg/dL with thirst and frequent urination; synthetic modern episode linked to the diabetes documented in her later lifeactiveconfirmed E11.65S — Synthetic modern diagnosis; diabetes is documented only at the end of her life.
Elevated blood pressure at intake (164/98 mmHg), without a diagnosis of hypertension; home readings for one week to confirmresolvedconfirmed R03.0S — Synthetic presenting finding, superseded by the confirmed diagnosis at two weeks.
Albumin in the urine (urine albumin-to-creatinine ratio 88 mg/g) and eGFR 73, in a woman whose kidneys were injured in a beating years ago; to be repeated and investigatedresolvedconfirmed R80.9S — Synthetic presenting finding, superseded by the kidney diagnosis at two weeks; the old kidney injury is documented.
Hypertension, stage 2, confirmed by home readings (average 152/94 mmHg), with chronic kidney disease; synthetic modern episode linked to the hypertension reported in her later lifeactiveconfirmed I12.9S — Synthetic modern diagnosis; hypertension is reported only at the end of her life.
Chronic kidney disease G2 A2 (eGFR 73, albumin-to-creatinine ratio 88 to 96 mg/g), with a small, scarred right kidney on ultrasound consistent with old injury; diabetes and high blood pressure likely contributeactiveconfirmed N18.2S — Synthetic kidney findings anchored to the documented permanent kidney damage.
Type 2 diabetes with diabetic chronic kidney disease (coded with the kidney disease by convention)activeconfirmed E11.22S — Synthetic modern coding.
Food insecurity: food runs out before the end of most monthsactiveconfirmed Z59.41S — Synthetic social need found on the screen.
Transportation insecurity: no car; the health center is a long drive away and rides are hard to arrangeactiveconfirmed Z59.82S — Synthetic social need anchored to her rural Delta home.
Hyperlipidemia: LDL 146 mg/dLactiveconfirmed E78.5S — Synthetic laboratory finding.

Results

DateMeasureValueUnitReference rangeFlagProvenance
1967-03-09Hemoglobin A1c/Hemoglobin.total in Blood8.6%Below 5.7% is normal; 6.5% or higher is diabetes; goal below 7% for herHighS
1967-03-09Glucose [Mass/volume] in Serum or Plasma238mg/dLRandom sample; 200 mg/dL or higher with symptoms is diagnostic of diabetesHighS
1967-03-09Sodium [Moles/volume] in Serum or Plasma139mmol/L135-145 mmol/LNormalS
1967-03-09Potassium [Moles/volume] in Serum or Plasma4.3mmol/L3.5-5.1 mmol/LNormalS
1967-03-09Creatinine [Mass/volume] in Serum or Plasma0.96mg/dL0.59-1.04 mg/dLNormalS
1967-03-09Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1962)/1.73 sq M73mL/min/{1.73_m2}90 or higher is normal; 60 to 89 is mildly decreased (G2)LowS
1967-03-09Albumin/Creatinine [Mass Ratio] in Urine88mg/gBelow 30 mg/g normal (A1); 30 to 300 moderately increased (A2)HighS
1967-03-09Cholesterol [Mass/volume] in Serum or Plasma228mg/dL<=199 mg/dLHighS
1967-03-09Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation146mg/dLGoal below 70 mg/dL with diabetes and kidney diseaseHighS
1967-03-09Cholesterol in HDL [Mass/volume] in Serum or Plasma44mg/dL>=50 mg/dLLowS
1967-03-09Triglyceride [Mass/volume] in Serum or Plasma190mg/dL<=149 mg/dLHighS
1967-03-09Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma24U/L7-35 U/LNormalS
1967-03-09Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma22U/L10-35 U/LNormalS
1967-03-09Hemoglobin [Mass/volume] in Blood12.6g/dL12-15.5 g/dLNormalS
1967-03-09Platelets [#/volume] in Blood by Automated count26810*3/uL150-400 10*3/uLNormalS
1967-03-09Thyrotropin [Units/volume] in Serum or Plasma2.1m[IU]/L0.4-4.5 mIU/LNormalS
1967-03-09Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]4{score}S
1967-03-09Accountable health communities (AHC) health-related social needs screening (HRSN) tool3{score}S
1967-03-23Albumin/Creatinine [Mass Ratio] in Urine96mg/gBelow 30 mg/g normal (A1); 30 to 300 moderately increased (A2)HighS
1967-05-04Sodium [Moles/volume] in Serum or Plasma140mmol/L135-145 mmol/LNormalS
1967-05-04Potassium [Moles/volume] in Serum or Plasma4.7mmol/L3.5-5.1 mmol/LNormalS
1967-05-04Creatinine [Mass/volume] in Serum or Plasma1.04mg/dL0.59-1.04 mg/dLNormalS
1967-05-04Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1962)/1.73 sq M66mL/min/{1.73_m2}90 or higher is normal; 60 to 89 is mildly decreased (G2)LowS
1967-05-04Cholesterol [Mass/volume] in Serum or Plasma154mg/dL<=199 mg/dLNormalS
1967-05-04Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation80mg/dLGoal below 70 mg/dL with diabetes and kidney diseaseNormalS
1967-05-04Cholesterol in HDL [Mass/volume] in Serum or Plasma46mg/dL>=50 mg/dLLowS
1967-05-04Triglyceride [Mass/volume] in Serum or Plasma142mg/dL<=149 mg/dLNormalS
1967-05-04Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma26U/L7-35 U/LNormalS
1967-07-13Hemoglobin A1c/Hemoglobin.total in Blood7.3%Below 5.7% is normal; 6.5% or higher is diabetes; goal below 7% for herHighS
1967-07-13Albumin/Creatinine [Mass Ratio] in Urine52mg/gBelow 30 mg/g normal (A1); 30 to 300 moderately increased (A2)HighS
1967-07-13Potassium [Moles/volume] in Serum or Plasma4.6mmol/L3.5-5.1 mmol/LNormalS
1967-07-13Creatinine [Mass/volume] in Serum or Plasma1.02mg/dL0.59-1.04 mg/dLNormalS
1967-07-13Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1962)/1.73 sq M67mL/min/{1.73_m2}90 or higher is normal; 60 to 89 is mildly decreased (G2)LowS
1967-07-13Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]3{score}S
1967-07-13Accountable health communities (AHC) health-related social needs screening (HRSN) tool1{score}S
1967-10-19Hemoglobin A1c/Hemoglobin.total in Blood6.9%Below 5.7% is normal; 6.5% or higher is diabetes; goal below 7% for herHighS
1967-10-19Albumin/Creatinine [Mass Ratio] in Urine41mg/gBelow 30 mg/g normal (A1); 30 to 300 moderately increased (A2)HighS
1967-10-19Potassium [Moles/volume] in Serum or Plasma4.5mmol/L3.5-5.1 mmol/LNormalS
1967-10-19Creatinine [Mass/volume] in Serum or Plasma1mg/dL0.59-1.04 mg/dLNormalS
1967-10-19Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1962)/1.73 sq M69mL/min/{1.73_m2}90 or higher is normal; 60 to 89 is mildly decreased (G2)LowS
1967-10-19Accountable health communities (AHC) health-related social needs screening (HRSN) tool1{score}S
1967-09-14Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]0{score}S

Social History

Vital Signs

DateMeasureValueUnitProvenance
1967-03-09Body height163cmS
1967-03-09Body weight93kgS
1967-03-09Body mass index (BMI) [Ratio]35kg/m2S
1967-03-09Systolic blood pressure164mm[Hg]S
1967-03-09Diastolic blood pressure98mm[Hg]S
1967-03-09Heart rate84/minS
1967-03-09Respiratory rate16/minS
1967-03-09Body temperature36.8CelS
1967-03-09Oxygen saturation in Arterial blood by Pulse oximetry98%S
1967-03-23Body height163cmS
1967-03-23Body weight92.6kgS
1967-03-23Body mass index (BMI) [Ratio]34.9kg/m2S
1967-03-23Systolic blood pressure156mm[Hg]S
1967-03-23Diastolic blood pressure96mm[Hg]S
1967-03-23Heart rate82/minS
1967-03-23Respiratory rate16/minS
1967-03-23Body temperature36.7CelS
1967-03-23Oxygen saturation in Arterial blood by Pulse oximetry98%S
1967-05-04Body height163cmS
1967-05-04Body weight91.8kgS
1967-05-04Body mass index (BMI) [Ratio]34.6kg/m2S
1967-05-04Systolic blood pressure136mm[Hg]S
1967-05-04Diastolic blood pressure84mm[Hg]S
1967-05-04Heart rate78/minS
1967-05-04Respiratory rate16/minS
1967-05-04Body temperature36.6CelS
1967-05-04Oxygen saturation in Arterial blood by Pulse oximetry98%S
1967-07-13Body height163cmS
1967-07-13Body weight90.9kgS
1967-07-13Body mass index (BMI) [Ratio]34.2kg/m2S
1967-07-13Systolic blood pressure128mm[Hg]S
1967-07-13Diastolic blood pressure78mm[Hg]S
1967-07-13Heart rate76/minS
1967-07-13Respiratory rate16/minS
1967-07-13Body temperature36.9CelS
1967-07-13Oxygen saturation in Arterial blood by Pulse oximetry98%S
1967-10-19Body height163cmS
1967-10-19Body weight90kgS
1967-10-19Body mass index (BMI) [Ratio]33.9kg/m2S
1967-10-19Systolic blood pressure124mm[Hg]S
1967-10-19Diastolic blood pressure76mm[Hg]S
1967-10-19Heart rate74/minS
1967-10-19Respiratory rate16/minS
1967-10-19Body temperature36.7CelS
1967-10-19Oxygen saturation in Arterial blood by Pulse oximetry98%S
1967-09-14Body height163cmS
1967-09-14Body weight90.4kgS
1967-09-14Body mass index (BMI) [Ratio]34kg/m2S
1967-09-14Systolic blood pressure126mm[Hg]S
1967-09-14Diastolic blood pressure78mm[Hg]S
1967-09-14Heart rate74/minS
1967-09-14Respiratory rate16/minS
1967-09-14Body temperature36.7CelS
1967-09-14Oxygen saturation in Arterial blood by Pulse oximetry98%S

Encounters

DatePurposeStatusProvenance
1967-03-09Establishing care at the rural community health center for high blood pressure readings, thirst and frequent urination, leg and back aching, and reduced vision in the left eye since an old injury, with consent-based, trauma-informed care and a social needs screenfinishedS
1967-03-23Two-week review of home blood pressure readings and the repeat urine test, with a kidney ultrasound and a nephrology telehealth consultation from the health centerfinishedS
1967-05-04Six-week review: blood pressure, kidney function and potassium after the new medicines, lipids, retinal photographs, and benefitsfinishedS
1967-07-13Four-month review: A1c, urine albumin, kidney function, mood, social needs, and the metformin dosefinishedS
1967-10-19Seven-month review: A1c, urine albumin, kidney function, seasonal and age-50 vaccines, screening results, and plans for the winterfinishedS
1967-09-14Periodic adult preventive visitfinishedS

Plan of Treatment

InterventionStatusGuidelineProvenance
Consent-based, trauma-informed care at every visit: explain each examination, test and procedure beforehand (what it is, why, what it involves, the alternatives, including not doing it), ask her agreement and record it, offer a chaperone or companion of her choosing, let her stop at any time, never perform an unplanned procedure, and keep the plan in writing; written consent for any procedure beyond routine testscompletedGL-SAMHSA-TIP57-2014, GL-AMA-CONSENT, GL-ACOG-CONSENT-2021S
Nephrology consultation by telehealth from the health center, with the community health worker present, for albumin in the urine and reduced kidney function in a woman with an old kidney injury, new diabetes and high blood pressure readingscompletedGL-KDIGO-CKD-2024, GL-ADA-CKD-2026S
Blood pressure: a validated home monitor with a large cuff, provided by the health center, with readings twice a day for seven days to confirm the diagnosis; less salt, using foods she can get; recheck in two weekscompletedGL-AHA-HTN-2025, GL-CMID-2026S
Diabetes: metformin extended-release once daily, an A1c every three months until at goal, diabetes self-management education in a group class at the health center, and no medicine that can cause low blood sugarcompletedGL-ADA-2026, GL-CMID-2026S
Kidneys: repeat the urine albumin test, a kidney ultrasound with the consultation, no ibuprofen or naproxen, and kidney function and potassium checks after any blood pressure or kidney medicine is startedcompletedGL-KDIGO-CKD-2024, GL-ADA-CKD-2026S
Cardiovascular risk: atorvastatin 40 mg with a lipid panel at four to twelve weeks, a baseline ECG, and TSH at diagnosiscompletedGL-ADA-2026, GL-AHA-HTN-2025, GL-CMID-2026S
Eyes and feet: retinal photographs in the clinic, so that no separate trip is needed; a comprehensive foot examination yearly; daily foot checks at home, callus care at the health center and well-fitting shoescompletedGL-ADA-RETFOOT-2026S
Social needs, with the community health worker: the AHC health-related social needs screen at intake and every few months; help applying for SNAP and the Low Income Home Energy Assistance Program; the health center's food pantry and produce program; 211 for other local help; rides arranged for every visit and laboratory test; the sliding-fee scale; 90-day medicine supplies at the discount pharmacy, and phone visits when travel is not possiblecompletedGL-AHC-HRSN, GL-ADA-POP-2026, GL-SNAP, GL-LIHEAPS
Shared decisions and the team: Dr. Batiste-Hill, a nurse, the community health worker and the pharmacist review the plan with her; medicines chosen for cost, once-daily dosing and her preferences; she decides what she acceptscompletedGL-ADA-2026, GL-ACOG-CONSENT-2021S
Mood and stress: PHQ-9 at intake and at four months, asked privately; counseling offered at her choicecompletedGL-USPSTF-DEP-2023, GL-CMID-2026S
Vaccines: pneumococcal, hepatitis B and Tdap offered, explained and given only with her agreement; influenza and COVID-19 each autumncompletedGL-CDC-IMZ-2026S
On the consultant's advice: amlodipine 5 mg with benazepril 20 mg in one daily capsule and dapagliflozin 10 mg daily with sick-day rules; potassium and creatinine one to two weeks after starting; urine albumin again at three to four months; blood pressure goal below 130/80; review of kidney treatment by telehealth if albumin stays raisedcompletedGL-KDIGO-CKD-2024, GL-ADA-CKD-2026, GL-AHA-HTN-2025S
Laboratory checks on the days she is already at the health center, with a ride arranged in advance for any extra check; home blood draw by the mobile phlebotomy service when no ride can be foundcompletedGL-ADA-POP-2026, GL-AHC-HRSNS
Metformin extended-release increased to 1,500 mg with the evening meal, because the A1c was still above goalcompletedGL-ADA-2026, GL-CMID-2026S

Goals

GoalTargetStatusOutcomeProvenance
Every examination, test and procedure explained first and done only with her documented agreement, with a chaperone of her choosing, at every visit1967-10-19completedConsent documented for every examination, blood draw, ultrasound, photograph, vaccine and screening test; she declined a breast and a pelvic examination, and that was respectedS
Blood pressure below 130/80 mmHg in the clinic and at home within six months1967-10-19completed124/76 in the clinic; home average 126/78S
A1c below 7% within six to nine months, without low blood sugar1967-10-19completed6.9% at seven months; no low blood sugarS
Urine albumin-to-creatinine ratio lower by at least 30% within six months1967-10-19completed88 to 96 mg/g at baseline; 41 mg/g at seven monthsS
Food and utility needs met through benefits, and a dependable way to reach every visit and laboratory test1967-10-19activeSNAP and energy assistance in place; rides arranged for every visit after one missed laboratory check; transportation still uncertain on some daysS
LDL cholesterol below 70 mg/dL1967-10-19active146 to 80 mg/dL on atorvastatin; recheck with the yearly panelS

Functional Status

Mental Status